Patriot Financial Group Insurance Agency, LLC Bei Gene, Ltd. Transaction History

Patriot Financial Group Insurance Agency, LLC

$720 Million
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	BUY	$146.52 - $269.56 $1,172 - $2,156	8 Added 133.33%	14 $3,000
Q4 2021 Jan 10, 2022	SELL	$248.56 - $389.34 $1,988 - $3,114	-8 Reduced 57.14%	6 $2,000
Q3 2021 Nov 24, 2021	BUY	$249.6 - $403.14 $1,996 - $3,225	8 Added 133.33%	14 $5,000
Q2 2020 Jul 10, 2020	SELL	$123.9 - $195.41 $1,115 - $1,758	-9 Reduced 60.0%	6 $1,000
Q1 2020 Apr 15, 2020	BUY	$121.84 - $173.19 $1,827 - $2,597	15 New	15 $2,000

Others Institutions Holding BGNE

# of Institutions

250

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

Baker Bros. Advisors LP New York, NY

10.6M
Shares

$2.01 Billion
25.41% of portfolio
Capital International Investors Los Angeles, CA

6.43M
Shares

$1.23 Billion
0.29% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

5.18M
Shares

$986 Million
26.65% of portfolio
Primecap Management CO Pasadena, CA

4.97M
Shares

$948 Million
0.84% of portfolio
Baillie Gifford & CO

3.71M
Shares

$706 Million
0.64% of portfolio

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $19.8B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patriot Financial Group Insurance Agency, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Patriot Financial Group Insurance Agency, LLC with notifications on news.

Account